Tapewire

Nasdaq · USD

IMCR

Immunocore Holdings plc

Export transactions ↓
Tapewire entity
4544
SEC CIK
0001671927
Parsed reports
61

Last 12 months

Inside the activity.

0 purchase rows · 10 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202502
Jan 202600
Feb 202604
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 27, 2024 Filed Feb 28, 2024 21:15 UTC
Berman David MHEAD OF R&D
SaleOrdinary Shares 3,394 $71.97 $244,266.18
Disclosure

SEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 8

Berman David M · CIK 0001955244 · HEAD OF R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.85 to $72.28 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 27, 2024 Filed Feb 28, 2024 21:15 UTC
Berman David MHEAD OF R&D
SaleOrdinary Shares 25,944 $71.32 $1,850,326.08
Disclosure

SEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 7

Berman David M · CIK 0001955244 · HEAD OF R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,394

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.84 to $71.8307 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 27, 2024 Filed Feb 28, 2024 21:15 UTC
Berman David MHEAD OF R&D
SaleOrdinary Shares 21,152 $70.42 $1,489,523.84
Disclosure

SEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 6

Berman David M · CIK 0001955244 · HEAD OF R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,338

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.835 to $70.8248 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 27, 2024 Filed Feb 28, 2024 21:15 UTC
Berman David MHEAD OF R&D
SaleOrdinary Shares 4,448 $69.45 $308,913.60
Disclosure

SEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 5

Berman David M · CIK 0001955244 · HEAD OF R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,490

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.835 to $69.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 27, 2024 Filed Feb 28, 2024 21:15 UTC
Berman David MHEAD OF R&D
Exercise / conversionOrdinary Shares 54,938 $17.46 $959,217.48
Disclosure

SEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 4

Berman David M · CIK 0001955244 · HEAD OF R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,938

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 21:15 UTC
Berman David MHEAD OF R&D
Exercise / conversionEmployee Share Option (Right to Buy) · Derivative 28,553 $0.00 Strike: $17.46 $0.00
Disclosure

SEC source: 0001415889-24-005720 · form4-02282024_040201.xml · derivative · entry 9

Berman David M · CIK 0001955244 · HEAD OF R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 363,237

Underlying: Ordinary Shares · 28,553 shares

Expires 2028-09-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023.

F8 · derivative.exercise_date: Immediately exercisable.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 21:15 UTC
Berman David MHEAD OF R&D
SaleOrdinary Shares 2,037 $71.31 $145,258.47
Disclosure

SEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 3

Berman David M · CIK 0001955244 · HEAD OF R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.09 to $71.685 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 21:15 UTC
Berman David MHEAD OF R&D
SaleOrdinary Shares 26,516 $70.60 $1,872,029.60
Disclosure

SEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 2

Berman David M · CIK 0001955244 · HEAD OF R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,037

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.09 to $71.088 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 26, 2024 Filed Feb 28, 2024 21:15 UTC
Berman David MHEAD OF R&D
Exercise / conversionOrdinary Shares 28,553 $17.46 $498,535.38
Disclosure

SEC source: 0001415889-24-005720 · form4-02282024_040201.xml · nonDerivative · entry 1

Berman David M · CIK 0001955244 · HEAD OF R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,553

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 21:16 UTC
St Leger Tina AmberCHIEF HR OFFICER
GrantEmployee Share Option (Right to Buy) · Derivative 14,162 $0.00 Strike: $70.50 $0.00
Disclosure

SEC source: 0001415889-24-004593 · form4-02212024_040226.xml · derivative · entry 1

St Leger Tina Amber · CIK 0001969525 · CHIEF HR OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,162

Underlying: Ordinary Shares · 14,162 shares

Expires 2034-02-15

F1 · derivative.exercise_date: 25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 21:15 UTC
Di Donato BrianCHIEF FINANCIAL OFFICER
GrantEmployee Share Option (Right to Buy) · Derivative 66,746 $0.00 Strike: $70.50 $0.00
Disclosure

SEC source: 0001415889-24-004592 · form4-02212024_040224.xml · derivative · entry 1

Di Donato Brian · CIK 0001766498 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,746

Underlying: Ordinary Shares · 66,746 shares

Expires 2034-02-15

F1 · derivative.exercise_date: 25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 21:15 UTC
GOLL JOHNSVP, FINANCE & CAO
GrantEmployee Share Option (Right to Buy) · Derivative 4,930 $0.00 Strike: $70.50 $0.00
Disclosure

SEC source: 0001415889-24-004594 · form4-02212024_040229.xml · derivative · entry 1

GOLL JOHN · CIK 0001779466 · SVP, FINANCE & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,930

Underlying: Ordinary Shares · 4,930 shares

Expires 2034-02-15

F1 · derivative.exercise_date: 25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 21:15 UTC
Berman David MHEAD OF R&D
GrantEmployee Share Option (Right to Buy) · Derivative 111,244 $0.00 Strike: $70.50 $0.00
Disclosure

SEC source: 0001415889-24-004591 · form4-02212024_040222.xml · derivative · entry 1

Berman David M · CIK 0001955244 · HEAD OF R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,244

Underlying: Ordinary Shares · 111,244 shares

Expires 2034-02-15

F1 · derivative.exercise_date: 25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 21:15 UTC
Jallal BahijaDirector · CHIEF EXECUTIVE OFFICER
GrantEmployee Share Option (Right to Buy) · Derivative 281,819 $0.00 Strike: $70.50 $0.00
Disclosure

SEC source: 0001415889-24-004590 · form4-02212024_040209.xml · derivative · entry 1

Jallal Bahija · CIK 0001730038 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 281,819

Underlying: Ordinary Shares · 281,819 shares

Expires 2034-02-15

F1 · derivative.exercise_date: 25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 21:17 UTC
St Leger Tina AmberChief HR Officer
Exercise / conversionEmployee Share Option (Right to Buy) · Derivative 4,375 $0.00 Strike: $29.87 $0.00
Disclosure

SEC source: 0001209191-24-001014 · doc4.xml · derivative · entry 4

St Leger Tina Amber · CIK 0001969525 · Chief HR Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,375

Underlying: Ordinary Shares · 4,375 shares

Expires 2032-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2023.

F4 · derivative.exercise_date: 25% of the shares subject to the option award vested on April 1, 2023, and 6.25% of the shares subject to the option award vested or shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 21:17 UTC
St Leger Tina AmberChief HR Officer
SaleOrdinary Shares 307 $70.46 $21,631.22
Disclosure

SEC source: 0001209191-24-001014 · doc4.xml · nonDerivative · entry 3

St Leger Tina Amber · CIK 0001969525 · Chief HR Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.40 to $70.66 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 21:17 UTC
St Leger Tina AmberChief HR Officer
SaleOrdinary Shares 4,068 $69.85 $284,149.80
Disclosure

SEC source: 0001209191-24-001014 · doc4.xml · nonDerivative · entry 2

St Leger Tina Amber · CIK 0001969525 · Chief HR Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 307

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.28 to $70.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 03, 2024 Filed Jan 5, 2024 21:17 UTC
St Leger Tina AmberChief HR Officer
Exercise / conversionOrdinary Shares 4,375 $29.87 $130,681.25
Disclosure

SEC source: 0001209191-24-001014 · doc4.xml · nonDerivative · entry 1

St Leger Tina Amber · CIK 0001969525 · Chief HR Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,375

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.